Roivant Sciences (ROIV) Common Equity (2020 - 2026)
Roivant Sciences (ROIV) recorded Common Equity of $4.92 billion in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 2.2% from $4.82 billion a year earlier but down 7.0% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences reported Common Equity of $5.29 billion, up 2.0% from FY2025.
- Annual Common Equity has a five-year compound annual growth rate of 21.0% (FY2021 to FY2026).
- Across earlier fiscal years, Common Equity came in at $5.19 billion in FY2025 (-19.6%), $6.45 billion in FY2024 (+301.1%), $1.61 billion in FY2023 (-21.2%) and $2.04 billion in FY2022 (unchanged).
- Quarterly Common Equity has ranged from $1.33 billion in fiscal Q2 2024 to $6.58 billion in fiscal Q3 2024 over the past five years.
- On a year-over-year basis, Common Equity rose in three of the last eight quarters, with growth averaging 30.9%.
- Peak year-over-year performance for Common Equity in the last five years was growth of 361.4% in fiscal Q3 2024, against a decline of 37.6% in fiscal Q2 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $5.29 billion (Q4 2026), $4.97 billion (Q3 2026) and $4.81 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Roivant Sciences | 26.72 Bn | 27.41 Bn | 1.16 Mn | 4.92 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.92 Bn |
| Mar 31, 2026 | 5.29 Bn |
| Dec 31, 2025 | 4.97 Bn |
| Sep 30, 2025 | 4.81 Bn |
| Jun 30, 2025 | 4.82 Bn |
| Mar 31, 2025 | 5.19 Bn |
| Dec 31, 2024 | 5.54 Bn |
| Sep 30, 2024 | 5.58 Bn |
| Jun 30, 2024 | 5.90 Bn |
| Mar 31, 2024 | 6.45 Bn |
| Dec 31, 2023 | 6.58 Bn |
| Sep 30, 2023 | 1.33 Bn |
| Jun 30, 2023 | 1.33 Bn |
| Mar 31, 2023 | 1.61 Bn |
| Dec 31, 2022 | 1.43 Bn |
| Sep 30, 2022 | 1.51 Bn |
| Jun 30, 2022 | 1.76 Bn |
| Mar 31, 2022 | 2.04 Bn |
| Dec 31, 2021 | 2.25 Bn |
| Sep 30, 2021 | 2.43 Bn |
API Access
Roivant Sciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();